Novel Common Genetic Susceptibility Loci for Colorectal Cancer.
Stephanie L Schmit,Christopher K Edlund,Fredrick R Schumacher,Jian Gong,Tabitha A Harrison,Jeroen R Huyghe,Chenxu Qu,Marilena Melas,David J Van Den Berg,Hansong Wang,Stephanie Tring,Sarah J Plummer,Demetrius Albanes,M Henar Alonso,Christopher I Amos,Kristen Anton,Aaron K Aragaki,Volker Arndt,Elizabeth L Barry,Sonja I Berndt,Stéphane Bezieau,Stephanie Bien,Amanda Bloomer,Juergen Boehm,Marie-Christine Boutron-Ruault,Hermann Brenner,Stefanie Brezina,Daniel D Buchanan,Katja Butterbach,Bette J Caan,Peter T Campbell,Christopher S Carlson,Jose E Castelao,Andrew T Chan,Jenny Chang-Claude,Stephen J Chanock,Iona Cheng,Ya-Wen Cheng,Lee Soo Chin,James M Church,Timothy Church,Gerhard A Coetzee,Michelle Cotterchio,Marcia Cruz Correa,Keith R Curtis,David Duggan,Douglas F Easton,Dallas English,Edith J M Feskens,Rocky Fischer,Liesel M FitzGerald,Barbara K Fortini,Lars G Fritsche,Charles S Fuchs,Manuela Gago-Dominguez,Manish Gala,Steven J Gallinger,W James Gauderman,Graham G Giles,Edward L Giovannucci,Stephanie M Gogarten,Clicerio Gonzalez-Villalpando,Elena M Gonzalez-Villalpando,William M Grady,Joel K Greenson,Andrea Gsur,Marc Gunter,Christopher A Haiman,Jochen Hampe,Sophia Harlid,John F Harju,Richard B Hayes,Philipp Hofer,Michael Hoffmeister,John L Hopper,Shu-Chen Huang,Jose Maria Huerta,Thomas J Hudson,David J Hunter,Gregory E Idos,Motoki Iwasaki,Rebecca D Jackson,Eric J Jacobs,Sun Ha Jee,Mark A Jenkins,Wei-Hua Jia,Shuo Jiao,Amit D Joshi,Laurence N Kolonel,Suminori Kono,Charles Kooperberg,Vittorio Krogh,Tilman Kuehn,Sébastien Küry,Andrea LaCroix,Cecelia A Laurie,Flavio Lejbkowicz,Mathieu Lemire,Heinz-Josef Lenz,David Levine,Christopher I Li,Li,Wolfgang Lieb,Yi Lin,Noralane M Lindor,Yun-Ru Liu,Fotios Loupakis,Yingchang Lu,Frank Luh,Jing Ma,Christoph Mancao,Frank J Manion,Sanford D Markowitz,Vicente Martin,Koichi Matsuda,Keitaro Matsuo,Kevin J McDonnell,Caroline E McNeil,Roger Milne,Antonio J Molina,Bhramar Mukherjee,Neil Murphy,Polly A Newcomb,Kenneth Offit,Hanane Omichessan,Domenico Palli,Jesus P Paredes Cotoré,Julyann Pérez-Mayoral,Paul D Pharoah,John D Potter,Conghui Qu,Leon Raskin,Gad Rennert,Hedy S Rennert,Bridget M Riggs,Clemens Schafmayer,Robert E Schoen,Thomas A Sellers,Daniela Seminara,Gianluca Severi,Wei Shi,David Shibata,Xiao-Ou Shu,Erin M Siegel,Martha L Slattery,Melissa Southey,Zsofia K Stadler,Mariana C Stern,Sebastian Stintzing,Darin Taverna,Stephen N Thibodeau,Duncan C Thomas,Antonia Trichopoulou,Shoichiro Tsugane,Cornelia M Ulrich,Franzel J B van Duijnhoven,Bethany van Guelpan,Joseph Vijai,Jarmo Virtamo,Stephanie J Weinstein,Emily White,Aung Ko Win,Alicja Wolk,Michael Woods,Anna H Wu,Kana Wu,Yong-Bing Xiang,Yun Yen,Brent W Zanke,Yi-Xin Zeng,Ben Zhang,Niha Zubair,Sun-Seog Kweon,Jane C Figueiredo,Wei Zheng,Loic Le Marchand,Annika Lindblom,Victor Moreno,Ulrike Peters,Graham Casey,Li Hsu,David V Conti,Stephen B Gruber
DOI: https://doi.org/10.1093/jnci/djy099
2019-01-01
Journal of the National Cancer Institute
Abstract:BACKGROUND:Previous genome-wide association studies (GWAS) have identified 42 loci (P < 5 × 10-8) associated with risk of colorectal cancer (CRC). Expanded consortium efforts facilitating the discovery of additional susceptibility loci may capture unexplained familial risk.METHODS:We conducted a GWAS in European descent CRC cases and control subjects using a discovery-replication design, followed by examination of novel findings in a multiethnic sample (cumulative n = 163 315). In the discovery stage (36 948 case subjects/30 864 control subjects), we identified genetic variants with a minor allele frequency of 1% or greater associated with risk of CRC using logistic regression followed by a fixed-effects inverse variance weighted meta-analysis. All novel independent variants reaching genome-wide statistical significance (two-sided P < 5 × 10-8) were tested for replication in separate European ancestry samples (12 952 case subjects/48 383 control subjects). Next, we examined the generalizability of discovered variants in East Asians, African Americans, and Hispanics (12 085 case subjects/22 083 control subjects). Finally, we examined the contributions of novel risk variants to familial relative risk and examined the prediction capabilities of a polygenic risk score. All statistical tests were two-sided.RESULTS:The discovery GWAS identified 11 variants associated with CRC at P < 5 × 10-8, of which nine (at 4q22.2/5p15.33/5p13.1/6p21.31/6p12.1/10q11.23/12q24.21/16q24.1/20q13.13) independently replicated at a P value of less than .05. Multiethnic follow-up supported the generalizability of discovery findings. These results demonstrated a 14.7% increase in familial relative risk explained by common risk alleles from 10.3% (95% confidence interval [CI] = 7.9% to 13.7%; known variants) to 11.9% (95% CI = 9.2% to 15.5%; known and novel variants). A polygenic risk score identified 4.3% of the population at an odds ratio for developing CRC of at least 2.0.CONCLUSIONS:This study provides insight into the architecture of common genetic variation contributing to CRC etiology and improves risk prediction for individualized screening.